BCTX - Briacell Therapeutics Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BCTX is currently covered by 1 analysts with an average price target of $18. This is a potential upside of $16.56 (1150%) from yesterday's end of day stock price of $1.44.

Briacell Therapeutics Corp's activity chart (see below) currently has 1 price targets and 6 ratings on display. The stock rating distribution of BCTX is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for BCTX is $18, Lowest price target is $18, average price target is $18.

Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 24-May-2024. First documented stock forecast 14-Feb-2022.

Best performing analysts who are covering BCTX - Briacell Therapeutics Corp:

Emily Bodnar

Currently out of the existing stock ratings of BCTX, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

18

$16.56 (1150.00%)

18

2 days ago

0/6 (0%)

$16.56 (1150.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BCTX (Briacell Therapeutics Corp) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on BCTX (Briacell Therapeutics Corp) with a proven track record?

EMILY BODNAR

Which analyst has the most public recommendations on BCTX (Briacell Therapeutics Corp)?

Emily Bodnar has 9 price targets and 8 ratings on BCTX

Which analyst is the currently most bullish on BCTX (Briacell Therapeutics Corp)?

Emily Bodnar with highest potential upside - $16.56

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?